Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

Hot topic

CROs' complex demands are changing the tissue supply biz, says industry expert

By Natalie Morrison , 27-Sep-2011
Last updated the 27-Sep-2011 at 09:49 GMT

CROs' complex demands are changing the tissue supply biz, says industry expert
CROs' complex demands are changing the tissue supply biz, says industry expert
Loading...

The human tissue supply industry is under pressure from CROs demanding more complex samples, according to equity analyst Vadim Alexandre.

Recently a trend for business dropping in the sector was highlighted by tissue specialist Asterand , whose share prices dropped by more than half.

Daniel Stewart analyst Alexandre attributes the changing nature of the business in large part to a split in the industry.

He told Outsourcing-Pharma that there is a low demand for simpler and easy to produce commodity samples.

Whereas for high spec samples – often difficult and even impossible to supply – the demand from contract research organisations (CROs) focusing their R&D efforts on complex and rare diseases has never been higher.

He said: “Requests for high spec tissues are getting increasingly complex and more diffuclt to supply.

“For example, in terms of cancer research, requests for tissue that is tissue naïve are coming in.

“What that means is tissue that comes from patients who haven’t been treated, and that obviously is very difficult to find.

“That’s just one example of the many reasons it is difficult for suppliers to meet demand.”

Kemwell CEO says environmental efforts are worth the cost

Kemwell CEO says environmental efforts are worth the cost

Kemwell CEO Agneta Bergvall says drugmakers' efforts to make pharmaceutical manufacturing green are worth...

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Will Downie

Senior VP Global Vusiness Development & Marketing, Catalent

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

Quincy Mattingly

Regional Manager, AlpVision

Cobra Biologics talks recent fill finish acquisition and future growth plans

Cobra Biologics talks recent fill finish acquisition and future growth plans

Philip Ridley-smith

Business Development & Marketing Manager, Cobra Biologics

Catalent says sharing with industry will not dull competetive edge

Catalent says sharing with industry will not dull competetive edge

Kurt Nielsen and Cornell Stamoran

Various, Catalent

Bend Research hunting new partnerships to boost bioavailability offering

Bend Research hunting new partnerships to boost bioavailability offering

David Lyon and Karen Coppens

Various, Bend Research and Dow

Changes to EU clinical trial laws will mean fairer playing field, says Clinipace

Changes to EU clinical trial laws will mean fairer playing field, says Clinipace

Andrea Schiefer

VP of European clinical operations and executive director of pharmacovigilance,...

Home visits = regulatory thumbs up? ResearchNurses.co thinks so

Home visits = regulatory thumbs up? ResearchNurses.co thinks so

Sue Mackay

Research nursing team manager, ResearchNurses.co

Consolidation prevalent in industry, says third largest CMO

Consolidation prevalent in industry, says third largest CMO

Brad Carlson

VP Marketing 7 Sales, Aenova

Catalent commits to ADCs by upping its stake in Redwood

Catalent commits to ADCs by upping its stake in Redwood

Aileen Ruff

Global Strategic Marketing Director, Biologics and Sterile Technologies at Catalent...

Kemwell Talks Expansion and Approvals in India and the US

Kemwell Talks Expansion and Approvals in India and the US

Christian Ahlmark

Director of Corporate Development , Kemwell Biopharma

AMRI Exec Discusses 'New Bar' in FDA Enforcement

Following the completion of remediation efforts to deal with an FDA warning letter, Chris...

Happy holidays from William Reed Business Media!

Happy holidays from William Reed Business Media!

The working year is almost done, time to pause from ‘the business’ and embrace...

Aesica says academic partnerships are key for CMOs

Aesica says academic partnerships are key for CMOs

Alan Raymond

Sales & Marketing Director, Aesica Pharmaceuticals

Wockhardt targets CMO space for diversification

Wockhardt targets CMO space for diversification

Tom Salus

Associate Vice President, Business Development - Contract Services, Wockhardt

Kemwell and Boehringer set to finish biologics plant in India

Kemwell and Boehringer set to finish biologics plant in India

Christian Ahlmark

Director of corporate development , Kemwell

Key Industry Events

 

Access all events listing

Our events, Events from partners...